针对炎症的纳米平台与抗氧化纳米氧化铁相结合,以减轻性结肠炎的进展
Haojun Chen1, Wei Sun2, Can Li3
1Co-Innovation Center for Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
这项研究开发了HA@ZIF-8@IONPs,这是一种用于治疗性结肠炎 (UC) 的新型纳米平台. 该纳米平台有效地向炎症和清理反应性氧物种 (ROS),显示UC治疗的希望.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 胃肠病学 胃肠病学
背景情况:
- 抗氧化纳米材料提供了潜在的性结肠炎 (UC) 通过清理反应性氧物种 (ROS) 治疗.
- 目前纳米材料的临床使用受到不良准,扩散和无活化的阻碍.
- 需要新的纳米平台来提高炎症性肠病的疗效和向性.
研究的目的:
- 开发和评估一种新的纳米平台,ZIF-8@IONPs,用于加强UC中的ROS清理和准.
- 通过氨酸 (HA) 表面修饰,提高ZIF-8@IONPs的准效率.
- 在UC小鼠模型中研究HA@ZIF-8@IONPs的治疗潜力.
主要方法:
- 铁氧化物纳米颗粒 (IONPs) 集成到二氧化物伊米达酸框架-8 (ZIF-8) 中,以创建ZIF-8@IONPs.
- 用氨酸 (HA) 修改ZIF-8@IONP的表面,以形成HA@ZIF-8@IONP,以增强准.
- 在RAW 264.7细胞中ROS清除和生物相容性的体外评估.
- 在性结肠炎小鼠模型中对HA@ZIF-8@IONPs的体内评估.
主要成果:
- ZIF-8@IONPs表现出良好的生物相容性和有效的ROS清理.
- HA@ZIF-8@IONPs表现出对炎症部位的增强向.
- 在UC小鼠模型中,用HA@ZIF-8@IONPs治疗显著减少了肠道组织损伤.
- 机理学研究发现ROS消除,Nrf2通路激活和NF-κB通路抑制由HA@ZIF-8@IONPs.
结论:
- HA@ZIF-8@IONPs代表了性结肠炎治疗的有前途的纳米平台.
- 纳米平台的有效性源于针对性地向炎症性微环境和强大的ROS清理提供.
- 这项研究为开发用于炎症性肠道疾病的先进纳米药物提供了基础.
更多相关视频
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
